Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA sued over ‘reckless and arbitrary’ semaglutide decision
The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.
FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over.
Blood pressure drug recalled due to black contaminants—FDA highlights safety risks
The recall was put in place after a customer discovered “visible black particulate matter” in a sealed vial. If the contaminant enters a patient's blood vessels, it could lead to serious complications, including a stroke or even death.
Cardiologist-founded startup raises $2M in the name of women’s heart health
Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.

FDA sued over ‘reckless and arbitrary’ semaglutide decision

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic

The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over.

Blood pressure drug recalled due to black contaminants—FDA highlights safety risks

The recall was put in place after a customer discovered “visible black particulate matter” in a sealed vial. If the contaminant enters a patient's blood vessels, it could lead to serious complications, including a stroke or even death.

healthcare value value-based care money dollar

Cardiologist-founded startup raises $2M in the name of women’s heart health

Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.

Philips to sell its emergency care business to private equity firm

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025.

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.

Withings, a French medtech company known for its remote monitoring devices, has multiple new services on display at CES 2025.

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes

Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.

Around the web

Cardiovascular Business

Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology.

Radiology Business

Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business

FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.